# The Prognostic Value of Serum Biomarkers in Osteosarcoma

> **NCT05093101** · — · COMPLETED · sponsor: **Istituto Ortopedico Rizzoli** · enrollment: 600 (actual)

## Conditions studied

- Osteosarcoma

## Interventions

- **OTHER:** case series review of clinical data

## Key facts

- **NCT ID:** NCT05093101
- **Lead sponsor:** Istituto Ortopedico Rizzoli
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-12
- **Primary completion:** 2021-12-22
- **Final completion:** 2021-12-22
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2022-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05093101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05093101, "The Prognostic Value of Serum Biomarkers in Osteosarcoma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05093101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*